High-resolution micro-CT for 3D infarct characterization and segmentation in mice stroke models.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 10 2022
19 10 2022
Historique:
received:
15
03
2022
accepted:
28
09
2022
entrez:
19
10
2022
pubmed:
20
10
2022
medline:
22
10
2022
Statut:
epublish
Résumé
Characterization of brain infarct lesions in rodent models of stroke is crucial to assess stroke pathophysiology and therapy outcome. Until recently, the analysis of brain lesions was performed using two techniques: (1) histological methods, such as TTC (Triphenyltetrazolium chloride), a time-consuming and inaccurate process; or (2) MRI imaging, a faster, 3D imaging method, that comes at a high cost. In the last decade, high-resolution micro-CT for 3D sample analysis turned into a simple, fast, and cheaper solution. Here, we successfully describe the application of brain contrasting agents (Osmium tetroxide and inorganic iodine) for high-resolution micro-CT imaging for fine location and quantification of ischemic lesion and edema in mouse preclinical stroke models. We used the intraluminal transient MCAO (Middle Cerebral Artery Occlusion) mouse stroke model to identify and quantify ischemic lesion and edema, and segment core and penumbra regions at different time points after ischemia, by manual and automatic methods. In the transient-ischemic-attack (TIA) mouse model, we can quantify striatal myelinated fibers degeneration. Of note, whole brain 3D reconstructions allow brain atlas co-registration, to identify the affected brain areas, and correlate them with functional impairment. This methodology proves to be a breakthrough in the field, by providing a precise and detailed assessment of stroke outcomes in preclinical animal studies.
Identifiants
pubmed: 36261475
doi: 10.1038/s41598-022-21494-9
pii: 10.1038/s41598-022-21494-9
pmc: PMC9582034
doi:
Substances chimiques
Osmium Tetroxide
P40W033BGM
Iodine
9679TC07X4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17471Informations de copyright
© 2022. The Author(s).
Références
J Cereb Blood Flow Metab. 2019 Feb;39(2):313-323
pubmed: 28829217
Stroke. 1986 Nov-Dec;17(6):1304-8
pubmed: 2433817
Croat Med J. 2013 Feb;54(1):3-11
pubmed: 23444240
Mol Imaging Biol. 2017 Jun;19(3):483
pubmed: 28389781
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Stroke. 2008 Dec;39(12):3372-7
pubmed: 18927459
Sci Rep. 2020 Oct 30;10(1):18772
pubmed: 33128010
Stroke. 1981 Nov-Dec;12(6):723-5
pubmed: 6272455
ACS Chem Neurosci. 2019 Aug 21;10(8):3404-3408
pubmed: 31274276
Brain Res. 2017 May 15;1663:166-173
pubmed: 28288870
Phys Med. 2014 Sep;30(6):619-34
pubmed: 24974176
Transl Stroke Res. 2016 Dec;7(6):548-561
pubmed: 27714669
J Neurosci Methods. 2008 Jun 30;171(2):207-13
pubmed: 18462802
J Neurosci. 2011 Mar 23;31(12):4622-35
pubmed: 21430162
Stroke. 1994 Jan;25(1):165-70
pubmed: 8266365
PLoS One. 2012;7(2):e32342
pubmed: 22384223
Biomed Opt Express. 2018 Dec 05;10(1):92-103
pubmed: 30775085
Sci Rep. 2016 Oct 11;6:35061
pubmed: 27725699
Stroke. 1989 Jan;20(1):84-91
pubmed: 2643202
Sci Rep. 2017 Jun 6;7(1):2858
pubmed: 28588216
Front Neurosci. 2021 Mar 17;15:627994
pubmed: 33815039
J Neurosci Methods. 2019 Dec 1;328:108416
pubmed: 31472188
J Neurosci Res. 2020 Feb;98(2):312-324
pubmed: 31630455
PeerJ. 2014 Jun 19;2:e453
pubmed: 25024921
PLoS One. 2017 Feb 8;12(2):e0170597
pubmed: 28178293
Nature. 2020 Sep;585(7825):357-362
pubmed: 32939066
Neuroimage. 2008 Aug 1;42(1):60-9
pubmed: 18502665
Acta Neuropathol. 1984;65(2):150-7
pubmed: 6084391
J Cereb Blood Flow Metab. 2019 Dec;39(12):2323-2342
pubmed: 31522590
Sci Rep. 2021 Mar 16;11(1):5999
pubmed: 33727592
PLoS One. 2015 Nov 16;10(11):e0142974
pubmed: 26571123
J Neuropathol Exp Neurol. 2010 Feb;69(2):188-95
pubmed: 20084015
PLoS One. 2019 May 29;14(5):e0216796
pubmed: 31141518
J Cereb Blood Flow Metab. 2000 Jul;20(7):1011-32
pubmed: 10908035
Br J Radiol. 2012 Nov;85(1019):e973-8
pubmed: 22674712
Front Neurosci. 2019 Oct 16;13:1105
pubmed: 31680838
Neuropharmacology. 2020 Oct 1;176:108202
pubmed: 32615189
BMC Med Imaging. 2018 Oct 30;18(1):38
pubmed: 30376825
Pathophysiology. 2010 Jun;17(3):197-218
pubmed: 20074922
J Cereb Blood Flow Metab. 2011 Sep;31(9):1836-51
pubmed: 21731034
J Anat. 2021 Aug;239(2):251-263
pubmed: 33782948
J Neurosci. 2020 Jul 29;40(31):6082-6097
pubmed: 32605940
J Neurosci Methods. 2014 Jan 15;221:70-7
pubmed: 24056228
J Cereb Blood Flow Metab. 2013 Mar;33(3):330-8
pubmed: 23232947
Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F493-F499
pubmed: 29167169
Stroke. 2014 Aug;45(8):2480-4
pubmed: 25013021
J Vis Exp. 2018 Nov 8;(141):
pubmed: 30474629
BMC Physiol. 2009 Jun 22;9:11
pubmed: 19545439
Sci Rep. 2020 Nov 30;10(1):20851
pubmed: 33257721
Front Neurol. 2022 Mar 11;13:846735
pubmed: 35359638
Biomed Res Int. 2019 Jul 14;2019:2054262
pubmed: 31392208
Int J Stroke. 2017 Jul;12(5):480-493
pubmed: 28697711
J Neurosci Methods. 2016 Sep 15;271:14-24
pubmed: 27345427
Elife. 2019 May 07;8:
pubmed: 31063133
Acta Neuropathol. 2017 Feb;133(2):245-261
pubmed: 28064357
Neuroimage. 2019 Nov 15;202:116109
pubmed: 31446129
Front Neuroanat. 2019 Jan 31;13:5
pubmed: 30766481
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Neuroreport. 1993 Dec 13;5(3):293-6
pubmed: 8298091
Stroke. 2014 May;45(5):1510-8
pubmed: 24652307
Nat Commun. 2020 Nov 6;11(1):5626
pubmed: 33159057
Sci Rep. 2017 Feb 07;7:41842
pubmed: 28169309